Page last updated: 2024-08-25

rosiglitazone and Bone Marrow Diseases

rosiglitazone has been researched along with Bone Marrow Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benko, I; Benko, K; Djazayeri, K; Rózsa, B; Szabó, B; Szentmiklósi, AJ; Szilvássy, Z1

Other Studies

1 other study(ies) available for rosiglitazone and Bone Marrow Diseases

ArticleYear
Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.
    Pharmacological research, 2006, Volume: 53, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Bone Regeneration; Female; Fluorouracil; Granulocytes; Hypoglycemic Agents; Leukocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrophils; Rosiglitazone; Thiazolidinediones

2006